Interestingly, larger injected masses (4.0 and 8.0 μg) also resulted in lower uptake of [18F]olaparib in the tumour plausibly caused by self-blocking, although the average PARP1 levels in all tissues are usually relatively high. The gene discussed is PARP1; the disease is neoplasm.